plerixafor has been researched along with Reperfusion Injury in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fricker, SP; Gershenovich, M; Ivanova, Y; Ledbetter, S; MacFarland, RT; Zuk, A | 1 |
Blanchard, J; Caldwell, CC; Edwards, MJ; Freeman, CM; Kuethe, JW; Lentsch, AB; Nojima, H; Quillin, RC; Schuster, R; Wilson, GC | 1 |
Li, XQ; Ma, H; Sun, XJ; Tan, WF; Zhang, ZL | 1 |
3 other study(ies) available for plerixafor and Reperfusion Injury
Article | Year |
---|---|
CXCRâ‚„antagonism as a therapeutic approach to prevent acute kidney injury.
Topics: Acute Kidney Injury; Animals; Benzylamines; Chemokine CXCL12; Cyclams; Flow Cytometry; Hematopoietic Stem Cells; Heterocyclic Compounds; Kidney Function Tests; Leukocytes; Male; Pyridines; Rats, Sprague-Dawley; Rats, Wistar; Receptors, CXCR4; Reperfusion Injury | 2014 |
CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice.
Topics: Adoptive Transfer; Animals; Benzylamines; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Cyclams; Disease Models, Animal; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hepatocytes; Heterocyclic Compounds; Leukocyte Common Antigens; Leukocytes, Mononuclear; Liver; Liver Diseases; Liver Regeneration; Male; Mice, Inbred C57BL; Receptors, CXCR4; Reperfusion Injury; Signal Transduction; Time Factors | 2015 |
Down-Regulation of CXCL12/CXCR4 Expression Alleviates Ischemia-Reperfusion-Induced Inflammatory Pain via Inhibiting Glial TLR4 Activation in the Spinal Cord.
Topics: Animals; Astrocytes; Behavior, Animal; Benzylamines; Chemokine CXCL12; Cyclams; Down-Regulation; Heterocyclic Compounds; Hyperalgesia; Inflammation; Microglia; Pain; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Reperfusion Injury; Spinal Cord; Sulfonamides; Toll-Like Receptor 4 | 2016 |